These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8577063)

  • 1. [Bone marrow transplantation for lysosomal storage diseases].
    Imaizumi M
    Nihon Rinsho; 1995 Dec; 53(12):3083-8. PubMed ID: 8577063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
    Maaswinkel-Mooij PD; Poorthuis BJ; Hoogerbrugge PM; Brouwer OF; Vossen JM
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):169-74. PubMed ID: 9557021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell bone marrow transplantation in patients with metabolic storage diseases.
    Krivit W
    Adv Pediatr; 2002; 49():359-78. PubMed ID: 12214779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on gene therapy for lysosomal storage diseases that affect hematopoiesis.
    Grabowski GA
    Curr Hematol Rep; 2003 Jul; 2(4):356-62. PubMed ID: 12901334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation and gene therapy for lysosomal storage diseases.
    Hoogerbrugge PM; Valerio D
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S34-6. PubMed ID: 9630322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation.
    Lessard MD; Alley TL; Proctor JL; Levy B; Galvin N; Vogler CA; Soper BW
    Clin Immunol; 2006 May; 119(2):166-79. PubMed ID: 16487752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation.
    Ohlemiller KK; Vogler CA; Roberts M; Galvin N; Sands MS
    Exp Eye Res; 2000 Nov; 71(5):469-81. PubMed ID: 11040082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches.
    Haskins M
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S25-7. PubMed ID: 8971403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of bone marrow transplantation for inborn errors of metabolism: a study of four patients with lysosomal storage diseases.
    Imaizumi M; Gushi K; Kurobane I; Inoue S; Suzuki J; Koizumi Y; Suzuki H; Sato A; Gotoh Y; Haginoya K
    Acta Paediatr Jpn; 1994 Feb; 36(1):30-6. PubMed ID: 8165905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
    Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
    Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS; Barker JE; Vogler C; Levy B; Gwynn B; Galvin N; Sly WS; Birkenmeier E
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mini review: animal model of human lysosomal storage disease].
    Sakiyama T
    Nihon Rinsho; 1995 Dec; 53(12):3105-11. PubMed ID: 8577067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for infantile ceramidase deficiency (Farber disease).
    Yeager AM; Uhas KA; Coles CD; Davis PC; Krause WL; Moser HW
    Bone Marrow Transplant; 2000 Aug; 26(3):357-63. PubMed ID: 10967581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation.
    Hsu YS; Hwu WL; Huang SF; Lu MY; Chen RL; Lin DT; Peng SS; Lin KH
    Bone Marrow Transplant; 1999 Jul; 24(1):103-7. PubMed ID: 10435744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for genetic and metabolic disorders.
    Schaison G; Bordigoni P; Leverger G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):119-23. PubMed ID: 2505227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for inherited diseases.
    O'Marcaigh AS; Cowan MJ
    Curr Opin Oncol; 1997 Mar; 9(2):126-30. PubMed ID: 9161789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correction of fatal genetic diseases using bone marrow transplantation. 1].
    Zintl F; Hermann J; Fuchs D; Prager J; Müller A; Reiners B; Füller J
    Kinderarztl Prax; 1991; 59(1-2):6-9. PubMed ID: 2056664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.